Expected growth in U.S. pharma profit 2019-2024 by drug type
The expected growth in U.S. pharma revenues will expand the sector's profit pool by 35 percent, from 126 billion to 170 billion U.S. dollars by 2024. With an overall 26 percent operating margin, pharma continues to be one of the most profitable healthcare sectors.